Use the tools in the order your team makes decisions: verify who is responsible, define the RFQ, establish the product specification, control the sample-to-batch transfer, review release evidence and document post-market follow-up. Each stage produces a record you can compare across suppliers.
Our downloadable analyses publish their query, denominator and limitations so buyers can reproduce the result without confusing database counts with market share or product quality.
The exact query returned 25 report rows across 10 event IDs. After event-level deduplication and manual scope review, six supplement or functional-nutrition gummy events supported four practical RFQ controls—without pretending the result is an industry recall rate.
Seven official API batches produced 3,007 unique on-market gummy/jelly label records across 512 named brands. Download the label-level and summary files, with an explicit boundary against market-share, quality or feasibility claims.
The output of one gate becomes the input to the next. A certificate, sample or laboratory report is useful only when its identity, scope, version and project relationship are clear.
Separate the U.S. coordination role from the manufacturing site, then record facility identity, scope, current documents, quality contacts and disclosure limits.
State the active, serving design, gummy base, target market, package, test scope, volume stage and delivery basis so suppliers are not evaluating different projects.
Open the gummy manufacturer RFQ template + Excel workbook →
Translate the label target into formula-space arithmetic · Compare two quotes by delivered, accepted bottle
Define identity, assay, physical, microbiological, packaging, sampling and change-control expectations before treating a prototype or COA as approval.
Record the approved sample, known scale differences, first-batch checks and change triggers instead of assuming a hand sample proves production equivalence.
Confirm sample identity, method suitability, units, specifications, batch linkage and review status before using a report or COA as claim support.
Review COA and batch records →
Evaluate a third-party lab report · Check stability evidence
Preserve containment, related-batch review, original data, disposition and corrective-action evidence. Keep external claims tied to the exact evidence approved for disclosure.
Begin with the supplier qualification checklist, factory verification page and certifications status page before sharing confidential formulation details.
Use the formula-space calculator and RFQ template, then normalize suppliers with the quote and landed-cost calculator. The complete guide library covers testing, specification, label, packaging and scale-up decisions.
Start from the product specification, then use the scale-up, laboratory, COA and stability tools to reconcile the evidence to the exact batch.
Regulatory boundary: these buyer tools organize questions and evidence. They do not replace required records, quality-unit review, legal advice, regulatory approval or a project-specific specification. FDA's dietary supplement CGMP guide and 21 CFR Part 111 describe record and quality-control responsibilities that buyers and manufacturers should evaluate in the context of the actual product and responsible parties.
FDA Dietary Supplement CGMP Small Entity Compliance Guide · 21 CFR Part 111
Share the product category, target market, serving direction, packaging and current volume stage. Commercial and technical assumptions remain subject to project review.
Start the Project Brief